Origin ID : SR174;
UMLS CUI : C1562242;
Currated CISMeF NLP mapping
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici
2024
France
scientific and technical information
safety
TNF Gene
Ustekinumab
inflammatory bowel disease, nos
tumor necrosis factor
Institutional Review Board Independent Ethics Committee Notification of Safety Information
Document
Physically Feel in Bad Condition
tumor necrosis factors
Safety Report
Clinical Trial Notification of Safety Information
chronic disease, nos
Vedolizumab
research report
vedolizumab
disease
Tumor Necrosis Factor
anti-TNF
Ustekinumab
Chronic Disease
pregnant women
inflammatory bowel diseases
vedolizumab
pregnancy, nos
albumin/globulin ratio
chronic disease
Gravida
---
https://www.rheuma-net.ch/fr/doc/anti-tnf/viewdocument/357
2024
Switzerland
guideline
Tumor Necrosis Factor Inhibitors
anti-TNF
Anti-Tumor Necrosis Factor Therapy
Background Treatment
tumor necrosis factor
---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-utilisation-biosimilaires-anti-tnf-alpha
2022
France
Biosimilars
anti-TNF
France
France
France
biosimilar pharmaceuticals
tumor necrosis factor alpha
france
french
France
tumor necrosis factor-alpha
---
http://www.cri-net.com/fiches-pratiques-et-eSessions/dernieres-mises-a-jour/traitements-anti-tnfa-et-suivi-de-tolerance
2020
France
guideline
tumor necrosis factor
anti-TNF
tumor necrosis factors
has patient
case management
---
http://www.sudoc.fr/232421579
2018
false
false
false
France
dissertations, academic
patients
Vaccination Coverage
tumor necrosis factor-alpha
cohort studies
has patient
tumor necrosis factor alpha
therapeutics
anti-TNF
preventive immunization/medication
---
https://www.inrs.fr/media.html?refINRS=TF%20241
2016
false
false
false
France
French
review of literature
legionellosis
Anti-Tumor Necrosis Factor Therapy
tumor necrosis factors
occupational exposure
risk
occupational diseases
occupational diseases
legionellosis
continuity of patient care
occupational medicine
Pontiac fever
occupational diseases
legionellosis
risk assessment
anti-TNF
Tumor Necrosis Factor Inhibitors
---
https://www.revmed.ch/RMS/2016/RMS-N-509/Spondyloarthropathies-traitements-conventionnels-et-anti-TNF
2016
false
false
false
Switzerland
French
journal article
spondylarthropathies
anti-inflammatory agents, non-steroidal
tumor necrosis factors
anti-TNF
Tumor Necrosis Factor Inhibitors
---
http://www.fmcgastro.org/postu-main/postu-2013-paris/textes-postu-2013-paris/ileite-terminale-refractaire
2013
false
true
false
false
France
treatment failure
crohn disease
anti-TNF
ileitis
teaching material
crohn disease
---
http://www.fmcgastro.org/postu-main/archives/postu-2012-%e2%80%93-paris/textes-postu-2012-paris/atelier-utilisation-des-anticorps-anti-tnf-a-dans-la-prise-en-charge-des-patients-atteints-de-maladies-inflammatoires-chroniques-intestinales-mici
2012
false
true
false
false
France
anti-TNF
crohn disease
colitis, ulcerative
inflammatory bowel diseases
Infliximab
Adalimumab
Infliximab
Adalimumab
tumor necrosis factors
gastrointestinal agents
teaching material
inflammatory bowel diseases
Contraindications, Drug
Tumor Necrosis Factor Inhibitors
---
http://www.fmcgastro.org/postu-main/archives/postu-2012-%e2%80%93-paris/textes-postu-2012-paris/tolerance-aux-biotherapies
2012
false
true
false
false
France
anti-TNF
Infliximab
Adalimumab
immunocompromised host
neoplasms
mass screening
crohn disease
colitis, ulcerative
inflammatory bowel diseases
inflammatory bowel diseases
Infections
opportunistic infections
skin diseases
joint diseases
nervous system diseases
inflammatory bowel diseases
antibodies, monoclonal
tumor necrosis factors
gastrointestinal agents
Infliximab
Adalimumab
Contraindications, Procedure
teaching material
Contraindications, Drug
Tumor Necrosis Factor Inhibitors
---
